                         SEQUENCE LISTING

<110>  University of Washington through its Center for 
       Commercialization
       PhaseRx, Inc.
       Monahan, S.D.
       Johnson, P.H.
       Diab, C.
       De, P.
       Stayton, P.S.
       Hoffman, A.S.
 
<120>  HYDROPHOBIC BLOCK CONJUGATED THERAPEUTIC AGENTS

<130>  UWOTL-1-35873

<150>  US 61/261186
<151>  2009-11-13

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  N at position 1 = G ribonucleotide

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  N at position 2 = 2'-O-methyl modified U

<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  N at position 3 = C ribonucleotide

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  N at position 4 = A ribonucleotide

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  N at position 5 = 2'-O-methyl modified U

<220>
<221>  misc_feature
<222>  (6)..(6)
<223>  N at position 6 = C ribonucleotide

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  N at position 7 = A ribonucleotide

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  N at position 8 = C ribonucleotide

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  N at position 9 = A ribonucleotide

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  N at position 10 = C ribonucleotide

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  N at position 11 = 2'-O-methyl modified U

<220>
<221>  misc_feature
<222>  (12)..(12)
<223>  N at position 12 = G ribonucleotide

<220>
<221>  misc_feature
<222>  (13)..(14)
<223>  N at position 13 and 14 = A ribonucleotide

<220>
<221>  misc_feature
<222>  (15)..(15)
<223>  N at position 15 = 2'-O-methyl modified

<220>
<221>  misc_feature
<222>  (16)..(16)
<223>  N at position 16 = A ribonucleotide

<220>
<221>  misc_feature
<222>  (17)..(18)
<223>  N at position 17 and 18 = C ribonucleotide

<220>
<221>  misc_feature
<222>  (19)..(20)
<223>  N at position 19 and 20 = A ribonucleotide

<220>
<221>  misc_feature
<222>  (21)..(21)
<223>  N at position 21 = 2'-O-methyl modified U

<400>  1
nnnnnnnnnn nnnnnnnnnn n                                                 21


<210>  2
<211>  23
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  misc_feature
<222>  (1)..(23)
<223>  Each of the nucleotides is ribonucleotide

<400>  2
auugguauuc agugugauga cac                                               23


<210>  3
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  3
cctaagatga gcgcaagttg aa                                                22


<210>  4
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  4
ccacaggact agaacacctg ct                                                22


<210>  5
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  5
atggaaggga agtggttact gt                                                22


<210>  6
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  6
gctttgtagg tgacctttgg ag                                                22


<210>  7
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  7
aagcacctcc gaaagtacgt g                                                 21


<210>  8
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  8
ctccagctct accttacagt tga                                               23


